1. Home
  2. NRXP vs MOGO Comparison

NRXP vs MOGO Comparison

Compare NRXP & MOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • MOGO
  • Stock Information
  • Founded
  • NRXP 2015
  • MOGO 2003
  • Country
  • NRXP United States
  • MOGO Canada
  • Employees
  • NRXP N/A
  • MOGO N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • MOGO
  • Sector
  • NRXP Health Care
  • MOGO
  • Exchange
  • NRXP Nasdaq
  • MOGO Nasdaq
  • Market Cap
  • NRXP 58.5M
  • MOGO 48.6M
  • IPO Year
  • NRXP N/A
  • MOGO N/A
  • Fundamental
  • Price
  • NRXP $2.89
  • MOGO $1.69
  • Analyst Decision
  • NRXP Strong Buy
  • MOGO Strong Buy
  • Analyst Count
  • NRXP 4
  • MOGO 1
  • Target Price
  • NRXP $28.50
  • MOGO $4.00
  • AVG Volume (30 Days)
  • NRXP 283.3K
  • MOGO 462.7K
  • Earning Date
  • NRXP 08-19-2025
  • MOGO 08-07-2025
  • Dividend Yield
  • NRXP N/A
  • MOGO N/A
  • EPS Growth
  • NRXP N/A
  • MOGO N/A
  • EPS
  • NRXP N/A
  • MOGO 0.12
  • Revenue
  • NRXP N/A
  • MOGO $30,265,570.00
  • Revenue This Year
  • NRXP N/A
  • MOGO $59.64
  • Revenue Next Year
  • NRXP $230.95
  • MOGO $5.55
  • P/E Ratio
  • NRXP N/A
  • MOGO $14.03
  • Revenue Growth
  • NRXP N/A
  • MOGO 0.18
  • 52 Week Low
  • NRXP $1.10
  • MOGO $0.74
  • 52 Week High
  • NRXP $6.01
  • MOGO $3.83
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 54.48
  • MOGO 48.92
  • Support Level
  • NRXP $2.30
  • MOGO $1.67
  • Resistance Level
  • NRXP $2.68
  • MOGO $1.80
  • Average True Range (ATR)
  • NRXP 0.19
  • MOGO 0.09
  • MACD
  • NRXP 0.02
  • MOGO -0.00
  • Stochastic Oscillator
  • NRXP 89.39
  • MOGO 56.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

Share on Social Networks: